An appeal in the Russian Federation forced ViiV Healthcare to terminate a patent license agreement with Promomed.
The Ninth Arbitration Court ordered the international pharmaceutical company ViiV Healthcare to provide JSC Biokhimik of the Promomed group with a license to use a patented invention used in anti-HIV drugs.